Lates News

CytoSorbents (CTSO.US): In the third quarter of 2025, the revenue reached 9.485 million US dollars, compared to the previous value of 8.613 million US dollars and the expected value of 9.934 million US dollars; the earnings per share were -0.04 US dollars, compared to the previous value of -0.08 US dollars and the expected value of -0.05 US dollars.